StoneX Group’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.09K Buy
+493
New +$5.54K ﹤0.01% 896
2024
Q3
Sell
-18
Closed -$4.55K 442
2024
Q2
$4.55K Buy
+18
New +$4.32K ﹤0.01% 338

Other funds holding ISPC

StoneX Group's ISPC Position: Q1 2026 in Review

StoneX Group opened a new position in iSpecimen (ISPC) in Q1 2026: 493 shares worth $3.09K. The stake represents ﹤0.01% of the portfolio and ranks #896 among its holdings. This is a return to the name: StoneX Group previously reported a position in ISPC as recently as Q2 2024.

StoneX Group first reported a position in ISPC in Q2 2024 and has held it in 2 quarters since. The position peaked at $4.55K in Q2 2024. 9 funds tracked by Wall St. Rank hold ISPC as of Q1 2026.

  • StoneX Group held 493 shares of iSpecimen worth $3.09K as of Q1 2026.
  • iSpecimen was a new StoneX Group position in Q1 2026.
  • iSpecimen made up ﹤0.01% of StoneX Group's portfolio in Q1 2026, its #896 holding.
  • StoneX Group first reported a position in iSpecimen in Q2 2024 and has held it in 2 quarters since.
  • StoneX Group's iSpecimen position peaked at $4.55K in Q2 2024.
  • 9 funds tracked by Wall St. Rank held iSpecimen as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.